| 2.255 -0.425 (-15.86%) | 12-15 15:59 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 3.9 |
1-year : | 4.71 |
| Resists | First : | 3.34 |
Second : | 4.03 |
| Pivot price | 2.84 |
|||
| Supports | First : | 2.21 |
Second : | 1.83 |
| MAs | MA(5) : | 2.65 |
MA(20) : | 2.86 |
| MA(100) : | 5.83 |
MA(250) : | 0 | |
| MACD | MACD : | -0.5 |
Signal : | -0.5  |
| %K %D | K(14,3) : | 28.6 |
D(3) : | 36.4 |
| RSI | RSI(14): 31.5 |
|||
| 52-week | High : | 690 | Low : | 2.21 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ STSS ] has closed below the lower bollinger band by 1.7%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ STSS ] is to continue within current trading range. It is unclear right now based on current values. 70.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 17 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 2.62 - 2.63 | 2.63 - 2.65 |
| Low: | 2.18 - 2.19 | 2.19 - 2.21 |
| Close: | 2.23 - 2.26 | 2.26 - 2.28 |
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
Fri, 28 Nov 2025
Sharps Technology Inc. Warrants Under Scrutiny: Delisting Fears, Digital Pivot, and High-Stakes Investment Potential - Markets Financial Content
Mon, 17 Nov 2025
Sharps Technology (STSS) Holds 2M+ SOL, Generates $17.7M Q3 Digital Asset Gains - Stock Titan
Mon, 17 Nov 2025
Sharps Technology stock sinks to record low after debut Solana-treasury quarterly filing - The Block
Thu, 09 Oct 2025
Solana treasury company Sharps Technology taps Coinbase for custody, liquidity, and OTC trading support - The Block
Mon, 06 Oct 2025
Sharps Technology settles litigation, agrees to asset and subsidiary transfer - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 0 (M) |
| Shares Float | 28 (M) |
| Held by Insiders | 2.665e+007 (%) |
| Held by Institutions | 0.1 (%) |
| Shares Short | 116 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.181e+008 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -131 % |
| Return on Assets (ttm) | 347.6 % |
| Return on Equity (ttm) | -32.6 % |
| Qtrly Rev. Growth | 306340 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | -22.08 |
| EBITDA (p.s.) | -1.02326e+006 |
| Qtrly Earnings Growth | -873.3 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -14 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.11 |
| Price to Cash Flow | 0.3 |
| Dividend | 0 |
| Forward Dividend | 168370 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|